Press Releases

AMA statement on FDA approval of implant to fight opioid addiction

| 1 Min Read

"The AMA is pleased the FDA approved a new implantable option to help treat patients with substance use disorders. With nearly 2 million Americans needing treatment for opioid use disorder, patients will benefit from increased options for medication-assisted treatment.

 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Giant gavel in a crowd of tiny figures

Why medical malpractice awards are on the rise

| 6 Min Read
Physicians and health care icons

A 4-step path to team-based rooming that saves physicians time

| 5 Min Read
Patient in discussion with physician

Amplifying the human touch while cutting documentation burden

| 7 Min Read
Athlete with a pained expression holds ankle

What doctors wish patients knew about ankle sprains and strains

| 10 Min Read